Navigation Links
David Anderson to discuss what model organisms can teach us about emotion
Date:2/20/2010

Scientists know little about how the brain creates and controls emotions an uncertainty that presents a major obstacle in the effort to develop treatments for emotional disorders. "The study of the brain science of emotion is in its infancy," says Howard Hughes Medical Institute (HHMI) investigator David Anderson, "yet emotional and psychiatric disorders continue to take an enormous toll on human society."

On February 20, 2010, at the American Association for the Advancement of Science's Annual Meeting in San Diego, Anderson, a neuroscientist at the California Institute of Technology, will discuss how studies of model organisms such as mice and fruit flies can improve scientists' understanding of the neural basis of emotion. That understanding, he says, is essential for developing more specific therapies for emotion disorders such as depression, anxiety, or attention deficit hyperactivity disorder (ADHD).

Anderson explains that while functional magnetic imaging (fMRI) studies of the human brain have linked neural activity in specific regions of the brain to particular emotional responses, there are limits to what can be learned from these types of studies. "We cannot tell which of these hotspots represents the actual cause of an emotional response, and which of them represents a reaction to the response," he says.

To makes that distinction, scientists must alter the activity of brain circuits in a targeted way, and then determine the consequences of the changes on emotional behavior. Such experiments are not possible on human subjects, and so scientists turn to model organisms. Anderson, whose own studies at Caltech and HHMI's Janelia Farm Research Campus explore the link between neural circuitry and emotional behaviors such as fear and aggression in both mice and fruit flies, will discuss the power and limitations of these types of experiments.

"We are in the midst of a revolution in the development of new technologies for experimentally manipulating brain circuitry," he says. Molecular and genetic tools that allow scientists to control when specific neurons are turned on in model organisms is already beginning to transform scientists' understanding of many aspects of brain function, including sensation, perception, cognition, and motor control. Anderson's presentation will address how to best apply these tools to the study of emotion.

"We need to know which animals are most suitable for studying this complex subject," he says. The laboratory mouse is amenable to powerful genetics techniques and it has a brain structure that is fundamentally similar to that of humans. But, he says, mouse research is slow, costly, technically difficult, and presents ethical challenges. Invertebrate model organisms, like the fruit fly Drosophila melanogaster, have simpler brains, more powerful genetic tools, and allow for faster, less expensive studies. "But can one study emotional behavior in a fly?" Anderson asks.


'/>"/>

Contact: Jennifer Michalowski
michalow@hhmi.org
301-215-8576
Howard Hughes Medical Institute
Source:Eurekalert

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
3. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
4. The Law Offices of John David Hart: Texas Man Sues Medtronic in Body-Snatching Case
5. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
6. St. Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders
7. David Grimes, FHI physician, inducted into Institute of Medicine
8. David Kahal Joins AXA Equitable as National Sales Manager
9. Leading Authority on Health Benefits, David Hom, Joins Board of Directors of Healthcare Technology Innovator, NavigatorMD, Inc.
10. Tree named in honor of Virginia Tech chemist David G.I. Kingston
11. David Luci Joins MacroChem as General Counsel and Vice President Corporate Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology: